|
|
|
|
Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker |
Authors: Sadr-Nabavi, A.; Ramser, J.; Volkmann, J.; Naehrig, J.; Wiesmann, F.; Betz, B.; Hellebrand, H.; Engert, S.; Seitz, S.; Kreutzfeld, R.; Sasaki, T.; Arnold, N.; Schmutzler, R.; Kiechle, M.; Niederacher, D.; Harbeck, N.; Dahl, E.; Meindl, A. | Date of Publication (YYYY-MM-DD): 2009-04-01 | Title of Journal: International Journal of Cancer | Volume: 124 | Issue / Number: 7 | Start Page: 1727 | End Page: 1735 | Document Type: Article | ID: 423858.0 |
|
|
The scope and number of records on eDoc is subject
to the collection policies defined by each institute
- see "info" button in the collection browse view.
|
|